History

2007

The company was founded in Denmark in 2007 by pharmacist Bo Tandrup. His mission was to develop top quality generic nicotine gums.

2011

Alkalon filed for European approval and started offering contract research and product development services to the pharmaceutical industry.

2008

Alkalon signed the first license and supply agreement with a large Pharma company, established a Swedish subsidiary in Helsingborg and started the development work.

2012

First launched by the Scandinavian partner Orifarm under the Nicovel® name Alkalon’s products reached the market in a number of European countries.

2009

Following a capital expansion, the company established a new R&D laboratory in Vejle and all in-house R&D activities were moved to Denmark.

2013

Alkalon's products were launched by STADA in France. Alkalon signed a co-development agreement with a large OTC company and started formulation development of a new medicated gum product.

2010

The company finalized formulation development and scale-up of its first products.

2014

Alkalon increased the focus on commercialisation of its nicotine gum portfolio. Bo Tandrup joined the Board and Bjarne Pedersen was appointed new CEO.